Agios Pharmaceuticals, Inc. (AGIO)
USD 24.53
(-5.29%)
USD 24.53
(-5.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -384.86 Million USD | 26.94% |
| 2022 | -380.48 Million USD | -36.8% |
| 2021 | -337.73 Million USD | -24.4% |
| 2020 | -326.12 Million USD | 25.99% |
| 2019 | -394.85 Million USD | -15.38% |
| 2018 | -338.85 Million USD | -12.99% |
| 2017 | -314.36 Million USD | -59.61% |
| 2016 | -195.27 Million USD | -69.32% |
| 2015 | -115.35 Million USD | -119.27% |
| 2014 | -52.76 Million USD | -39.22% |
| 2013 | -37.44 Million USD | -78.23% |
| 2012 | -21.81 Million USD | -37.81% |
| 2011 | -15.83 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -104.22 Million USD | -14.88% |
| 2024 Q3 | -102.81 Million USD | 1.36% |
| 2024 Q1 | -90.72 Million USD | 13.49% |
| 2023 Q3 | -100.89 Million USD | -7.68% |
| 2023 Q1 | -90.61 Million USD | 59.77% |
| 2023 FY | - USD | 26.94% |
| 2023 Q2 | -93.7 Million USD | -3.41% |
| 2023 Q4 | -104.87 Million USD | -3.94% |
| 2022 Q4 | -225.21 Million USD | -140.73% |
| 2022 Q3 | -93.55 Million USD | 4.59% |
| 2022 Q2 | -98.05 Million USD | 3.27% |
| 2022 Q1 | -101.37 Million USD | 5.68% |
| 2022 FY | - USD | -36.8% |
| 2021 Q4 | -107.47 Million USD | -18.18% |
| 2021 Q1 | -88.73 Million USD | 3.17% |
| 2021 FY | - USD | -24.4% |
| 2021 Q2 | -90.87 Million USD | -2.4% |
| 2021 Q3 | -90.93 Million USD | -0.07% |
| 2020 Q4 | -91.64 Million USD | -5.57% |
| 2020 FY | - USD | 25.99% |
| 2020 Q1 | -40.71 Million USD | 61.56% |
| 2020 Q3 | -86.81 Million USD | -0.95% |
| 2020 Q2 | -85.99 Million USD | -111.2% |
| 2019 Q4 | -105.92 Million USD | 0.98% |
| 2019 Q2 | -111.82 Million USD | -17.12% |
| 2019 Q1 | -95.47 Million USD | 0.91% |
| 2019 FY | - USD | -15.38% |
| 2019 Q3 | -106.97 Million USD | 4.33% |
| 2018 Q2 | -71.21 Million USD | 24.25% |
| 2018 Q1 | -94.01 Million USD | -4.31% |
| 2018 Q4 | -96.35 Million USD | 1.04% |
| 2018 FY | - USD | -12.99% |
| 2018 Q3 | -97.36 Million USD | -36.73% |
| 2017 Q3 | -77.4 Million USD | 6.77% |
| 2017 Q4 | -90.13 Million USD | -16.44% |
| 2017 FY | - USD | -59.61% |
| 2017 Q1 | -65.45 Million USD | -14.02% |
| 2017 Q2 | -83.02 Million USD | -26.84% |
| 2016 Q1 | -23.59 Million USD | 42.31% |
| 2016 FY | - USD | -69.32% |
| 2016 Q3 | -62.07 Million USD | -9.93% |
| 2016 Q4 | -57.4 Million USD | 7.52% |
| 2016 Q2 | -56.47 Million USD | -139.34% |
| 2015 Q1 | -5.19 Million USD | 80.56% |
| 2015 FY | - USD | -119.27% |
| 2015 Q4 | -40.89 Million USD | -1.04% |
| 2015 Q3 | -40.47 Million USD | -25.96% |
| 2015 Q2 | -32.13 Million USD | -518.54% |
| 2014 Q2 | -18 Million USD | -46.56% |
| 2014 Q1 | -12.28 Million USD | -0.34% |
| 2014 FY | - USD | -39.22% |
| 2014 Q4 | -26.72 Million USD | -852.03% |
| 2014 Q3 | 3.55 Million USD | 119.74% |
| 2013 Q3 | -10.69 Million USD | -31.16% |
| 2013 Q2 | -8.15 Million USD | -21.73% |
| 2013 Q1 | -6.69 Million USD | -8.47% |
| 2013 FY | - USD | -78.23% |
| 2013 Q4 | -12.24 Million USD | -14.5% |
| 2012 FY | - USD | -37.81% |
| 2012 Q2 | -5.85 Million USD | -17.0% |
| 2012 Q3 | -4.79 Million USD | 18.1% |
| 2012 Q4 | -6.17 Million USD | -28.87% |
| 2012 Q1 | -5 Million USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -6.86 Million USD | -5503.727% |
| Jaguar Health, Inc. | -33.13 Million USD | -1061.643% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -152.905% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -578.127% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -49.032% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 478.33% |
| ContextLogic Inc. | -324 Million USD | -18.785% |
| MiMedx Group, Inc. | 40.51 Million USD | 1049.883% |
| MEI Pharma, Inc. | 26.38 Million USD | 1558.923% |
| AlloVir, Inc. | -190.14 Million USD | -102.404% |
| Novavax, Inc. | -487.39 Million USD | 21.036% |
| Aptorum Group Limited | -9.59 Million USD | -3909.419% |
| Ardelyx, Inc. | -55.35 Million USD | -595.278% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -119.081% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -13887.018% |
| Vaxcyte, Inc. | -464.88 Million USD | 17.213% |
| Precigen, Inc. | -89.22 Million USD | -331.336% |
| Pharming Group N.V. | 9.87 Million USD | 3996.568% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -141.978% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1590.818% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2166.439% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -64.826% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2041.292% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1496.158% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1496.158% |
| Bicycle Therapeutics plc | -183.4 Million USD | -109.85% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -340.212% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1228.813% |
| Acelyrin, Inc. | -381.52 Million USD | -0.875% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 72853.119% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1052.771% |
| Senti Biosciences, Inc. | -61.33 Million USD | -527.468% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -242.698% |
| AbCellera Biologics Inc. | -192.15 Million USD | -100.285% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1145.353% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -132.657% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -119795.327% |
| Chimerix, Inc. | -92.97 Million USD | -313.948% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1085.912% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1809.142% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -766.095% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -721.271% |
| Elevation Oncology, Inc. | -41.46 Million USD | -828.121% |
| Alkermes plc | 495.04 Million USD | 177.743% |
| Fortress Biotech, Inc. | -133.64 Million USD | -187.979% |
| Fortress Biotech, Inc. | -133.64 Million USD | -187.979% |
| Agenus Inc. | -145.92 Million USD | -163.743% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -397.607% |
| Dyadic International, Inc. | -8.22 Million USD | -4576.503% |
| ImmuCell Corporation | -2.5 Million USD | -15269.495% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -132155.67% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -195.094% |
| Lantern Pharma Inc. | -15.78 Million USD | -2337.902% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2285.179% |
| Incyte Corporation | 919.42 Million USD | 141.859% |
| IO Biotech, Inc. | -91.22 Million USD | -321.87% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -441.879% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1832.786% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -570.776% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -144.832% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -4483.897% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -414.422% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -1.288% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 28.719% |
| NextCure, Inc. | -59.03 Million USD | -551.881% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -3760.995% |
| Onconetix, Inc. | -36.7 Million USD | -948.484% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 17319.866% |
| Opthea Limited | -200.01 Million USD | -92.414% |
| PDS Biotechnology Corporation | -40.08 Million USD | -860.12% |
| PureTech Health plc | -11.62 Million USD | -3210.089% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -390.316% |
| Seer, Inc. | -97.88 Million USD | -293.18% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -2986840.517% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1569.113% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -6192.179% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1215.415% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -554.642% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1521.504% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -215.196% |
| ChromaDex Corporation | -3.89 Million USD | -9783.513% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -5490.703% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -241.998% |
| CRISPR Therapeutics AG | -202.7 Million USD | -89.868% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1101.124% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -123.461% |
| Innoviva, Inc. | 248.96 Million USD | 254.589% |
| Summit Therapeutics Inc. | 1 Million USD | 38547.952% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -518.782% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -488.792% |
| ESSA Pharma Inc. | -26.45 Million USD | -1354.77% |
| GlycoMimetics, Inc. | -39.12 Million USD | -883.754% |
| GT Biopharma, Inc. | 5.97 Million USD | 6536.929% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -86.201% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 543.33% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -651.409% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -3792.664% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -62.649% |
| Aptose Biosciences Inc. | -52.26 Million USD | -636.328% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -257.204% |
| Soligenix, Inc. | -7.85 Million USD | -4800.947% |
| Century Therapeutics, Inc. | -121.2 Million USD | -217.524% |
| Kura Oncology, Inc. | -164.95 Million USD | -133.315% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -380.491% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -3715.824% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -40084.643% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -8831.631% |
| Autolus Therapeutics plc | -156.77 Million USD | -145.496% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -354.616% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -457.766% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1830.691% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -103.338% |
| GRI Bio, Inc. | -10.89 Million USD | -3431.51% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -8422.77% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -214.159% |
| IGM Biosciences, Inc. | -253.35 Million USD | -51.905% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -270.803% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -909.262% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2410.38% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2344.63% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -577.041% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -259.34% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -44.687% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -98.446% |
| Verastem, Inc. | -83.16 Million USD | -362.766% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -661.022% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -143.234% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -237.337% |
| Histogen Inc. | -10.5 Million USD | -3564.324% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2595.181% |
| Surrozen, Inc. | -41.13 Million USD | -835.703% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2499.379% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 12000848.363% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -555.498% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -650.31% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1686.824% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -4515.78% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -131.753% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -681.315% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1492.585% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2456.38% |
| Apollomics, Inc. | -171.74 Million USD | -124.088% |
| Amarin Corporation plc | -50.9 Million USD | -656.095% |
| Mesoblast Limited | -61.33 Million USD | -527.52% |
| Turnstone Biologics Corp. | -56.23 Million USD | -584.397% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -168.758% |
| Synaptogenix, Inc. | -8.3 Million USD | -4532.726% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2409.055% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -510.44% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7932.281% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 89803.733% |
| Exelixis, Inc. | 196.6 Million USD | 295.758% |
| Better Therapeutics, Inc. | -38.26 Million USD | -905.865% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -172.164% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 22.283% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3162.761% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 155779.244% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1204.358% |
| Gritstone bio, Inc. | -126.86 Million USD | -203.37% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -492.235% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -9521.73% |
| Avid Bioservices, Inc. | -11.48 Million USD | -3252.182% |
| Insmed Incorporated | -654.73 Million USD | 41.219% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -17007.203% |
| MediWound Ltd. | -4.89 Million USD | -7765.604% |
| OmniAb, Inc. | -49.73 Million USD | -673.892% |
| Alector, Inc. | -142.89 Million USD | -169.339% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -350.481% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -638.023% |
| Zai Lab Limited | -366.57 Million USD | -4.99% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -32.421% |
| Aura Biosciences, Inc. | -83.69 Million USD | -359.836% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -70.862% |
| Immunic, Inc. | -99.11 Million USD | -288.312% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -192.294% |
| Veracyte, Inc. | -49.4 Million USD | -678.935% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -5348.298% |
| FibroGen, Inc. | -261.4 Million USD | -47.229% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3354.483% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -5397.014% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1956.242% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 126.553% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1413.901% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1064.813% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1574.575% |
| Galecto, Inc. | -37.51 Million USD | -925.784% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -905.786% |
| Fortrea Holdings Inc. | 167.3 Million USD | 330.044% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -186.613% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1259.415% |
| XBiotech Inc. | -35.76 Million USD | -976.061% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -492.235% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -489.83% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -268.45% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1399.159% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -841.748% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 25.48% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -587.0% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -686531.817% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -230.824% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1636.002% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -63.727% |
| NexImmune, Inc. | -28.16 Million USD | -1266.34% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -6865.173% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -3163.697% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 108.269% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1415.69% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3185.743% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -205.821% |
| Ainos, Inc. | -8.77 Million USD | -4286.865% |
| Pluri Inc. | -20.22 Million USD | -1802.912% |
| Prothena Corporation plc | -190.1 Million USD | -102.445% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -200.211% |
| Celularity Inc. | -183.94 Million USD | -109.227% |
| Rallybio Corporation | -72.37 Million USD | -431.778% |
| Cue Biopharma, Inc. | -46.05 Million USD | -735.716% |
| MeiraGTx Holdings plc | -57.05 Million USD | -574.585% |
| Omeros Corporation | -163.61 Million USD | -135.233% |
| Humacyte, Inc. | -96.45 Million USD | -298.996% |
| Immunocore Holdings plc | -59.64 Million USD | -545.215% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1886.702% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1479.577% |
| Blueprint Medicines Corporation | -474.61 Million USD | 18.91% |
| CalciMedica, Inc. | -34.18 Million USD | -1025.695% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -425.526% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -206.672% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -128.472% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -52.488% |
| Pulmatrix, Inc. | -12.64 Million USD | -2943.365% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1067.457% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -335.037% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 23.987% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -280.244% |
| Cytokinetics, Incorporated | -456.68 Million USD | 15.726% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1053.22% |
| Nutriband Inc. | -5.12 Million USD | -7414.267% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -789.407% |
| Vor Biopharma Inc. | -114.37 Million USD | -236.505% |
| Roivant Sciences Ltd. | -996.51 Million USD | 61.379% |
| Evogene Ltd. | -23.2 Million USD | -1558.611% |
| ProKidney Corp. | -147.66 Million USD | -160.626% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -496.365% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -251200.368% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 31.939% |
| CorMedix Inc. | -48.88 Million USD | -687.252% |
| BioLineRx Ltd. | -57.06 Million USD | -574.478% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -244.373% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -190426.733% |
| Atai Life Sciences N.V. | -36.31 Million USD | -959.91% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -384.002% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -373.312% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -39.695% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1151.997% |
| MediciNova, Inc. | -9.87 Million USD | -3795.396% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -205.591% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -25051.206% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1343.126% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -71.058% |
| Biomea Fusion, Inc. | -124.62 Million USD | -208.83% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -16.505% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1377.065% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -102.199% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -67.374% |
| Absci Corporation | -95.45 Million USD | -303.18% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1181.812% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -259.29% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -64.841% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1583.938% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -85.177% |
| Allakos Inc. | -189.91 Million USD | -102.651% |
| Imunon, Inc. | -19.87 Million USD | -1836.103% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -254.74% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 455.29% |
| BioAtla, Inc. | -122.24 Million USD | -214.84% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3162.761% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -2341.876% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -28.163% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -828.569% |
| XOMA Corporation | -39.36 Million USD | -877.755% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -287.757% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -227.126% |
| aTyr Pharma, Inc. | -52.17 Million USD | -637.598% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -359.183% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -158.939% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -64.076% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -2718.897% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -4685.497% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2190.584% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 204049.0% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 185.157% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5924.207% |
| UroGen Pharma Ltd. | -63.83 Million USD | -502.942% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -466.685% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5198.959% |
| Orgenesis Inc. | -60.71 Million USD | -533.855% |
| Entera Bio Ltd. | -8.8 Million USD | -4271.468% |
| GH Research PLC | -41.15 Million USD | -835.203% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1408.147% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -368.016% |
| Xencor, Inc. | -125.87 Million USD | -205.753% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -26878.749% |
| Replimune Group, Inc. | -230.19 Million USD | -67.188% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1809.273% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -3417.309% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5924.207% |
| Portage Biotech Inc. | -18.19 Million USD | -2014.754% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -25051.206% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -267.995% |
| OncoCyte Corporation | -23.12 Million USD | -1564.421% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3305.767% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3259.251% |
| Purple Biotech Ltd. | -22.22 Million USD | -1631.672% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -5904.119% |
| scPharmaceuticals Inc. | -46.06 Million USD | -735.553% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2060.982% |
| HilleVax, Inc. | -132.46 Million USD | -190.538% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -3519.524% |
| Tharimmune, Inc. | -9.3 Million USD | -4037.171% |
| Genprex, Inc. | -31.06 Million USD | -1139.076% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -105.232% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1127.48% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -50274.869% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 255138.965% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2444121.882% |
| Savara Inc. | -59.13 Million USD | -550.845% |
| Curis, Inc. | -45.13 Million USD | -752.62% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1153.567% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2433.475% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -5271.445% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1339.605% |
| BeiGene, Ltd. | -1.12 Billion USD | 65.778% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -2260.955% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 10.618% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -326.017% |
| Erasca, Inc. | -121.31 Million USD | -217.257% |
| bluebird bio, Inc. | -167.16 Million USD | -130.236% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -8454.898% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 224.036% |
| DBV Technologies S.A. | -85.98 Million USD | -347.61% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -8454.898% |
| Moderna, Inc. | -3.28 Billion USD | 88.277% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -803.246% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -6714.164% |
| Molecular Templates, Inc. | 1.43 Million USD | 27013.566% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -543.026% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -17.967% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -180.74% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -712.532% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -176.813% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -86.954% |
| MacroGenics, Inc. | 2.01 Million USD | 19181.011% |
| RenovoRx, Inc. | -11.39 Million USD | -3278.964% |
| Adicet Bio, Inc. | -136.53 Million USD | -181.879% |
| Prime Medicine, Inc. | -193.75 Million USD | -98.63% |
| Aditxt, Inc. | -25.45 Million USD | -1411.763% |
| Adagene Inc. | -14.95 Million USD | -2474.206% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5164.827% |
| Quantum-Si incorporated | -91.8 Million USD | -319.224% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 154.023% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 404.349% |
| SciSparc Ltd. | -5.28 Million USD | -7186.331% |
| Vericel Corporation | 2.86 Million USD | 13537.989% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -404134.938% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1674.268% |
| Generation Bio Co. | -133.3 Million USD | -188.72% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -363.524% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -347.397% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -69.22% |
| Invivyd, Inc. | -196.61 Million USD | -95.745% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -2.863% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -4049.567% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1517.338% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3641.993% |
| 2seventy bio, Inc. | -206.41 Million USD | -86.449% |
| ADMA Biologics, Inc. | 5.12 Million USD | 7616.875% |
| Clene Inc. | -43.24 Million USD | -790.044% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1572.669% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -693.911% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1343.126% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -28.474% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -947.838% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1732.648% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 7937.964% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1084.853% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -142.964% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 43.758% |
| Evaxion Biotech A/S | -21.4 Million USD | -1698.178% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -479.484% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -76.812% |
| Trevena, Inc. | -35.28 Million USD | -990.637% |
| Surrozen, Inc. | -41.13 Million USD | -835.703% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -383.546% |
| Cingulate Inc. | -22.95 Million USD | -1576.819% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -5058.343% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -932.277% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -4578.418% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -276.336% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -467.42% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -559.33% |
| Clearmind Medicine Inc. | -8.71 Million USD | -4318.309% |
| Kronos Bio, Inc. | -121.83 Million USD | -215.902% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -417.694% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -15663.979% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -281.707% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1088.479% |
| ImmunityBio, Inc. | -436.18 Million USD | 11.765% |
| Korro Bio, Inc. | -80.9 Million USD | -375.705% |
| Kineta, Inc. | -15.71 Million USD | -2349.179% |
| BioVie Inc. | -31.95 Million USD | -1104.574% |
| Codexis, Inc. | -49.28 Million USD | -680.926% |
| Celularity Inc. | -183.94 Million USD | -109.227% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -73.746% |
| Celcuity Inc. | -58.3 Million USD | -560.031% |
| Virax Biolabs Group Limited | -6.6 Million USD | -5723.205% |
| Cibus, Inc. | -314.58 Million USD | -22.34% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1040.912% |
| IN8bio, Inc. | -28.5 Million USD | -1250.21% |
| Kodiak Sciences Inc. | -259.02 Million USD | -48.583% |
| Annexon, Inc. | -141.57 Million USD | -171.845% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -241.801% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -499.514% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1276.727% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -67.325% |
| Eyenovia, Inc. | -24.1 Million USD | -1496.546% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 959.378% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -118685.185% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -421.468% |
| Arcellx, Inc. | -64.14 Million USD | -499.991% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -754.987% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -211.691% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1146.241% |
| Moolec Science SA | -52.07 Million USD | -639.049% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -645.774% |
| Geron Corporation | -174.78 Million USD | -120.197% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -852.233% |
| Royalty Pharma plc | 1.88 Billion USD | 120.393% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -221.811% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4027.558% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1755.593% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -131.734% |
| Humacyte, Inc. | -96.45 Million USD | -298.996% |
| Structure Therapeutics Inc. | -102.45 Million USD | -275.627% |
| 89bio, Inc. | -134.46 Million USD | -186.223% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -387.942% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 9598.124% |
| Genelux Corporation | -24.16 Million USD | -1492.651% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1038.651% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -135.443% |
| Notable Labs, Ltd. | -14.4 Million USD | -2572.667% |
| Liquidia Corporation | -70.05 Million USD | -449.405% |
| Mustang Bio, Inc. | -48.06 Million USD | -700.749% |
| Immunovant, Inc. | -269.97 Million USD | -42.554% |
| Quantum-Si incorporated | -91.8 Million USD | -319.224% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -442.169% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1893.288% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -277.273% |
| Acasti Pharma Inc. | -11.3 Million USD | -3305.575% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1629.474% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2410.38% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -82.822% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -8912.484% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2323.577% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1237.448% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -939.33% |
| PepGen Inc. | -83.58 Million USD | -360.463% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1204.447% |
| United Therapeutics Corporation | 1.38 Billion USD | 127.752% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1580.849% |
| Solid Biosciences Inc. | -93.43 Million USD | -311.91% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -7965.492% |
| Immuneering Corporation | -58.06 Million USD | -562.864% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 12000848.363% |
| Silo Pharma, Inc. | -3.62 Million USD | -10513.384% |
| Belite Bio, Inc | -31.52 Million USD | -1120.667% |
| XOMA Corporation | -39.36 Million USD | -877.755% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -470.617% |
| Bionomics Limited | -9.83 Million USD | -3812.414% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -358.253% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1012.131% |
| uniQure N.V. | -253.1 Million USD | -52.06% |
| Cassava Sciences, Inc. | -95.68 Million USD | -302.211% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5164.827% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -197.183% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1085.036% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -4680.638% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1263.847% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -118685.185% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3354.483% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2320.376% |
| Altimmune, Inc. | -87.93 Million USD | -337.669% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -317.972% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1012.131% |
| Compugen Ltd. | -12.51 Million USD | -2974.976% |
| Peak Bio, Inc. | -1356.23 USD | -28377387.594% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -691.934% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1611.267% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -58.836% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1248.366% |
| Zura Bio Limited | -60.56 Million USD | -535.477% |
| PolyPid Ltd. | -20.26 Million USD | -1799.344% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2365.023% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1248.366% |
| Instil Bio, Inc. | -146.12 Million USD | -163.385% |
| argenx SE | -216.02 Million USD | -78.159% |
| Immunome, Inc. | -28.27 Million USD | -1261.338% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -693.976% |
| Verona Pharma plc | -52.46 Million USD | -633.527% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -306.095% |
| Shattuck Labs, Inc. | -87.61 Million USD | -339.267% |
| CervoMed Inc. | -2.17 Million USD | -17620.365% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -214.833% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -2932.096% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -698.904% |
| Moolec Science SA | -52.07 Million USD | -639.049% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2145.416% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -195.161% |
| AnaptysBio, Inc. | -143.16 Million USD | -168.827% |
| Design Therapeutics, Inc. | -66.32 Million USD | -480.27% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -375.217% |
| NeurAxis, Inc. | -6.66 Million USD | -5674.841% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -919.507% |
| Lumos Pharma, Inc. | -36.57 Million USD | -952.404% |
| Achilles Therapeutics plc | -70.44 Million USD | -446.356% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -306.095% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1638.789% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 6702.294% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -15663.979% |
| Nutriband Inc. | -5.12 Million USD | -7414.267% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -250.68% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -594.299% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -661.353% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -489.586% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -611.263% |
| Palisade Bio, Inc. | -12.28 Million USD | -3033.816% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -748.166% |
| Beam Therapeutics Inc. | -156.47 Million USD | -145.962% |
| Neurogene Inc. | -52.28 Million USD | -636.075% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -181.972% |
| AEON Biopharma, Inc. | -48.36 Million USD | -695.815% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -313.752% |
| Sesen Bio, Inc. | -50.84 Million USD | -657.01% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -369.736% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3016.302% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 9.959% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -265.851% |
| Athira Pharma, Inc. | -116.7 Million USD | -229.781% |
| Vaccinex, Inc. | -19.74 Million USD | -1848.876% |
| HCW Biologics Inc. | -23.57 Million USD | -1532.436% |
| XOMA Corporation | -39.36 Million USD | -877.755% |
| Nektar Therapeutics | -243.1 Million USD | -58.311% |
| Arvinas, Inc. | -394.8 Million USD | 2.517% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 204049.0% |
| Merus N.V. | -149.2 Million USD | -157.94% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -311.663% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1131.171% |
| Rezolute, Inc. | -68.42 Million USD | -462.478% |
| Clene Inc. | -43.24 Million USD | -790.044% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2395.521% |
| BeyondSpring Inc. | -21.54 Million USD | -1686.741% |
| Synlogic, Inc. | -55.16 Million USD | -597.71% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -3085.169% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -3516.463% |
| Peak Bio, Inc. | -1356.23 USD | -28377387.594% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1085.474% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2249.598% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -224.991% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -12.749% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -8254.926% |
| MannKind Corporation | 15.12 Million USD | 2643.883% |
| Ikena Oncology, Inc. | -74.39 Million USD | -417.311% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -2956.174% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1993.364% |
| Gossamer Bio, Inc. | -172.15 Million USD | -123.561% |
| CohBar, Inc. | -12.06 Million USD | -3089.721% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1408.738% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1181.812% |
| Legend Biotech Corporation | -477.87 Million USD | 19.463% |
| Mural Oncology plc | -192.72 Million USD | -99.701% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -237.44% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2283.757% |
| Disc Medicine, Inc. | -91.02 Million USD | -322.811% |
| Champions Oncology, Inc. | -5.05 Million USD | -7515.038% |
| REGENXBIO Inc. | -239.46 Million USD | -60.719% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3490.757% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -590.265% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -892.729% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -241.173% |
| Vaxart, Inc. | -74.72 Million USD | -415.054% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -993.106% |
| Cellectis S.A. | -98.09 Million USD | -292.338% |
| Longeveron Inc. | -20.06 Million USD | -1818.564% |
| Repare Therapeutics Inc. | -114.27 Million USD | -236.793% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 12.371% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -414.442% |
| Revolution Medicines, Inc. | -430.58 Million USD | 10.618% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -6019.637% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1150.005% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -415.973% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 7949.561% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -3409.932% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 108.357% |
| Denali Therapeutics Inc. | -179.97 Million USD | -113.845% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -404134.938% |
| Veru Inc. | -89.97 Million USD | -327.743% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1331.892% |
| Cingulate Inc. | -22.95 Million USD | -1576.819% |
| Passage Bio, Inc. | -98.34 Million USD | -291.357% |
| Context Therapeutics Inc. | -25.06 Million USD | -1435.735% |
| Exicure, Inc. | -15.53 Million USD | -2376.762% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -86.769% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -940.848% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -6354.638% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -128.455% |
| Nuvalent, Inc. | -149.49 Million USD | -157.448% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -4632.469% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -348.069% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1175.313% |
| OmniAb, Inc. | -49.73 Million USD | -673.892% |
| Anew Medical, Inc. | -1.3 Million USD | -29485.806% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3012.779% |
| Lipocine Inc. | -16.32 Million USD | -2257.85% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -477.267% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -417.966% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -909.262% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -886.477% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1634.95% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 29.392% |
| Ocugen, Inc. | -64.82 Million USD | -493.679% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -315.755% |
| Q32 Bio Inc. | -86.5 Million USD | -344.919% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2173.669% |
| Alumis Inc. Common Stock | -156.89 Million USD | -145.308% |
| Equillium, Inc. | -12.13 Million USD | -3070.737% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -558.202% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4769.632% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1940.531% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -724.261% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -261.901% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2051.69% |
| Dominari Holdings Inc. | -22.44 Million USD | -1615.08% |
| Edesa Biotech, Inc. | -8.19 Million USD | -4599.113% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1414.497% |
| Bio-Techne Corporation | 326.66 Million USD | 217.817% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 277.857% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -193.547% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -928.196% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -154.706% |
| Nkarta, Inc. | -120.48 Million USD | -219.44% |
| BioCardia, Inc. | -11.56 Million USD | -3229.273% |
| Iterum Therapeutics plc | -34.58 Million USD | -1012.967% |